Cytodyn Inc (CYDY)

[Leronlimab4DaWin]

Updated Clinical Trial Analysis

Veru just reported its phase II (N=38) in hospitalized patients
18 took Veru pill and 1 died (5.6% death rate)
20 took placebo and 6 died (30% death rate)

If you think Leronlimab will have a similar results, you are sorely mistaken. The interim of n=195 had a total deaths of 45, in which approximately:
131 received Leronlimab
64 received placebo

If the interim results looked like Veru's, total deaths would have been 26-27 (13%) , not 45 (23%)

131 * 5.6% = 7
64 * 30% = 19

Seems like CD12 results are being delayed for a reason ;)